REVIEU - A multinational, retrospective, observational drug utilisation study of REVOLADE™ (eltrombopag) In selected countries in the European Union (201108)

30/06/2014
02/07/2024
EU PAS number:
EUPAS6969
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

weukbre7133-protocol-redact

English (1.49 MB - PDF) View document
Updated protocol

gsk-201108-protocol-redact

First published: 22/02/2024
English (1.86 MB - PDF) View document
Study results
Study results

gsk-201108-clinical-study-report-redact

English (9.63 MB - PDF) View document
Study report
Other information